Jan
4
Merck Makes Deal to Develop Schizophrenia Drug
January 4th, 2008 posted by
admin
Add comments
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
